U.S. Markets closed
  • S&P 500

    4,185.47
    +15.05 (+0.36%)
     
  • Dow 30

    34,200.67
    +164.68 (+0.48%)
     
  • Nasdaq

    14,052.34
    +13.58 (+0.10%)
     
  • Russell 2000

    2,262.67
    +5.60 (+0.25%)
     
  • Crude Oil

    63.07
    -0.39 (-0.61%)
     
  • Gold

    1,777.30
    +10.50 (+0.59%)
     
  • Silver

    26.04
    +0.08 (+0.29%)
     
  • EUR/USD

    1.1980
    +0.0004 (+0.0359%)
     
  • 10-Yr Bond

    1.5730
    +0.0430 (+2.81%)
     
  • Vix

    16.25
    -0.32 (-1.93%)
     
  • GBP/USD

    1.3840
    +0.0056 (+0.4069%)
     
  • USD/JPY

    108.7830
    +0.0670 (+0.0616%)
     
  • BTC-USD

    60,965.79
    -897.41 (-1.45%)
     
  • CMC Crypto 200

    1,398.97
    +7.26 (+0.52%)
     
  • FTSE 100

    7,019.53
    +36.03 (+0.52%)
     
  • Nikkei 225

    29,683.37
    +40.68 (+0.14%)
     

The Zacks Analyst Blog Highlights: Comcast, Thermo Fisher, Philip Morris, Morgan Stanley and Zoom Video

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Zacks Equity Research
·5 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

For Immediate Release

Chicago, IL – February 3, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Comcast Corporation CMCSA, Thermo Fisher Scientific Inc. TMO, Philip Morris International Inc. PM, Morgan Stanley MS and Zoom Video Communications, Inc. ZM.

Here are highlights from Tuesday’s Analyst Blog:

Q4 Earnings Season Scorecard and Research Reports for Comcast, Thermo Fisher and Philip Morris

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Comcast, Thermo Fisher Scientific and Philip Morris International. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Q4 Earnings Season Scorecard

For the 202 S&P 500 members or 40.4% of the index's membership that have reported Q4 results are down -1.7% from the same period last year on -1.8% lower revenues, with 80.2% beating EPS estimates and 77.2% beating revenue estimates. This is better than we have seen from this group of companies in the first three quarters of 2020.

The overall earnings outlook continues to improve, with estimates for the current period (2021 Q1) and the full year steadily going up. 

Comcast shares have outperformed the Zacks Cable Television industry over the past year (+17.5% vs. +11.1%). The Zacks analyst believes that Comcast is experiencing weakness in hospitality and advertising. The company expects Sky’s first quarter revenues to decline slightly year-over-year.

Weakness in film business is also a headwind. Moreover, the balance sheet remains significantly leveraged, which is a concern. Furthermore, Comcast has persistently suffered video-subscriber attrition due to cord-cutting.

However, its fourth-quarter 2020 results were driven by solid growth in high-speed Internet, Business Services, Wireless and advertising segments. Coronavirus has been a tailwind to Comcast’s broadband and wireless businesses. The growth in advertising revenues reflected an increase in political advertising revenues.

(You can read the full research report on Comcast here >>>)

Shares of Thermo Fisher have gained +23% in the last six months against the Zacks Medical Instruments industry’s gain of +7.3%. The Zacks analyst believes that Thermo Fisher has been expanding inorganic growth profile with several takeovers including Advanced Bioprocessing buyout from BD and Patheon.

In terms of end market, pharma and biotech registered growth in the fourth quarter of 2020 on the back of robust performance in bioproduction and pharma services. In diagnostics and healthcare, the company experienced exceptionally high demand for COVID-19 testing.

Also, the company’s strong capital structure is encouraging. However, the coronavirus outbreak has massively disrupted the global supply chain. Foreign currency fluctuations and competitive landscape are major downsides.

(You can read the full research report on Thermo Fisher here >>>)

Philip Morris shares have gained +10.1% over the past three months against the Zacks Tobacco industry’s rise of +10.6%. The Zacks analyst believes that the company has long been benefiting from its pricing power, which continued to aid its third-quarter 2020 results.

Also, management raised its earnings guidance for 2020 on the back of improved shipment volume trends, though the latter is still expected to decline. However, the management does not expect a near-term recovery in the duty-free business due to travel-related uncertainties amid the pandemic.

Also, a delay in minimum price enforcement in Indonesia is a concern. This apart, cigarette volumes have been soft for a while due to rising health consciousness and stern regulations. All said, revenues are likely to fall in 2020. Nonetheless, strength in RRPs, especially IQOS, is expected to offer respite.

(You can read the full research report on Philip Morris here >>>)

Other noteworthy reports we are featuring today include Morgan Stanley and Zoom Video.

Zacks Names “Single Best Pick to Double”

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

You know this company from its past glory days, but few would expect that it’s poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com                                      

https://www.zacks.com                                          

 

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Comcast Corporation (CMCSA) : Free Stock Analysis Report
 
Philip Morris International Inc. (PM) : Free Stock Analysis Report
 
Zoom Video Communications, Inc. (ZM) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research